Avid Bioservices Inc (CDMO)

[north40000]

The President repeated these views today in talk to Congressional leaders in W.Va., per CNBC-TV.

http://thehill.com/policy/healthcare/371733-right-to-try-act-gains-momentum-after-trump-pitch

The Senate bill, passed by unanimous consent in 2017, has been discussed on this message board last year.

IMO, if House acts, CDMO should be prepared to send appropriate Bavituximab family member in storage to MSKCC/Ludwig CC and NCCN researchers, with appropriate license provisions for milestone and royalties. Safety is a given in light of numerous Phase 1 trials.

golfho, what think thou?:

"Revenue from the sale of our IP? Grrrrr…. Don’t get me started…I’m not one who believes that the IP is worth $20B now. But I think that any thing less that $2B (The Abbott Labs offer in 2012) for the whole IP would be a shame after all these years. An offer of $100M to $500M up front with a percentage of profit if commercialized, would be very acceptable. An offer of a few million and a promise of something years down the road will bring a flock of vultures to the funeral."

Sounds like an inexpensive gamble to me.